Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein – A position paper from the IFCC Committee on bone metabolism
•Brief presentation of the metabolism of vitamin D.•Detailed presentation of preanalytical variables affecting the measurement of vitamin D metabolites.•Detailed presentation and recommendations on the analytical measurement and clinical usefulness of vitamin D metabolites.•Current status and future...
Saved in:
Published in: | Clinica chimica acta Vol. 517; pp. 171 - 197 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-06-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Brief presentation of the metabolism of vitamin D.•Detailed presentation of preanalytical variables affecting the measurement of vitamin D metabolites.•Detailed presentation and recommendations on the analytical measurement and clinical usefulness of vitamin D metabolites.•Current status and future goals for the standardization of analytical methods.
Vitamin D, an important hormone with a central role in calcium and phosphate homeostasis, is required for bone and muscle development as well as preservation of musculoskeletal function. The most abundant vitamin D metabolite is 25-hydroxyvitamin D [25(OH)D], which is currently considered the best marker to evaluate overall vitamin D status. 25(OH)D is therefore the most commonly measured metabolite in clinical practice. However, several other metabolites, although not broadly measured, are useful in certain clinical situations. Vitamin D and all its metabolites are circulating in blood bound to vitamin D binding protein, (VDBP). This highly polymorphic protein is not only the major transport protein which, along with albumin, binds over 99% of the circulating vitamin D metabolites, but also participates in the transport of the 25(OH)D into the cell via a megalin/cubilin complex.
The accurate measurement of 25(OH)D has proved a difficult task. Although a reference method and standardization program are available for 25(OH)D, the other vitamin D metabolites still lack this. Interpretation of results, creation of clinical supplementation, and generation of therapeutic guidelines require not only accurate measurements of vitamin D metabolites, but also the accurate measurements of several other “molecules” related with bone metabolism.
IFCC understood this priority and a committee has been established with the task to support and continue the standardization processes of vitamin D metabolites along with other bone-related biomarkers.
In this review, we present the position of this IFCC Committee on Bone Metabolism on the latest developments concerning the measurement and standardization of vitamin D metabolites and its binding protein, as well as clinical indications for their measurement and interpretation of the results. |
---|---|
Bibliography: | CRediT authorship contribution statement Konstantinos Makris: Conceptualization, Writing - original draft. Harjit P Bhattoa: Writing - review & editing. Etienne Cavalier: Supervision, Writing - review & editing. Karen Phinney: Writing - review & editing. Christopher T. Sempos: Writing - review & editing. Candice Z. Ulmer: Writing - review & editing. Samuel D. Vasikaran: Writing - review & editing. Hubert Vesper: Writing - review & editing. Annemieke C. Heijboer: Conceptualization, Writing - original draft. |
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/j.cca.2021.03.002 |